RLMD
Relmada Therapeutics, Inc. · Healthcare
Chief Financial Officer Maged Shenouda bought $844K of Relmada Therapeutics, Inc.
Bought$843,990
$4.22Price
200,000Shares
+25%Stake
What RLMD did for a copier
- $1,000 copied at Fri, Sep 11 open, $4.60
- $698
- S&P 500, same days
- +1.1%
28 of 30 trading days so far, to the Oct 21 close.
Maged Shenouda's record
5 other buys with 3 months of prices since 2019: on average −3.7% against the S&P 500, and 2 of 5 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Sep 9. Filed Fri, Sep 11, 7:30 AM ET, before the open. Returns use the Sep 11 open and the Oct 21 close. Not investment advice.